Notice of Special Interest to Highlight High Priority Opportunities for Intervention Development Research in Geriatric Mental Health
https://grants.nih.gov/grants/guide/notice-files/NOT-MH-20-027.html
notice number: not-mh-20-027key dates release date: march 19, 2020 first available due date: june 05, 2020 expiration date: september 08, 2023pa-19-055, research project grant (parent r01 clinical trial required)pa-19-094, emotion regulation, aging and mental disorder (r01 clinical trial not allowed)pa-19-095, emotion regulation, aging and mental disorder (r21 clinical trial not allowed)par-18-941, neuromodulation/neurostimulation device development for mental health applications (r21 clinical trial optional)par-18-942, neuromodulation/neurostimulation device development for mental health applications (r01 clinical trial optional)rfa-mh-18-700, clinical trials to test the effectiveness of treatment, preventive, and services interventions (collaborative r01 - clinical trial required)rfa-mh-18-701, clinical trials to test the effectiveness of treatment, preventive, and services interventions (r01 clinical trial required)rfa-mh-18-702, early stage testing of pharmacologic or device-based interventions for the treatment of mental disorders (r61/r33- clinical trial required)rfa-mh-18-703, early stage testing of pharmacologic or device-based interventions for the treatment of mental disorders (r33- clinical trial required)rfa-mh-18-704, development of psychosocial therapeutic and preventive interventions for mental disorders (r61/r33- clinical trial required)rfa-mh-18-705, development of psychosocial therapeutic and preventive interventions for mental disorders (r33 clinical trial required)rfa-mh-18-706, pilot effectiveness trials for treatment, preventive and services interventions (r34- clinical trial required)rfa-mh-18-707, confirmatory efficacy clinical trials of non-pharmacological interventions for mental disorders (r01 clinical trial required)issued by national institute of mental health (nimh)purposenimh is issuing this notice to highlight its interest in supporting intervention development activities for older adults. although controlled clinical trial data on age differences in the efficacy of interventions for mental disorders are seldom available, clinical experience suggests that many psychopharmacological agents show reduced efficacy in older adults as well as greater risks for the occurrence of adverse side effects. in older adults with dementia, the increased mortality risks have been deemed significant enough for the fda to issue a black box warning concerning the use of antipsychotic agents with this patient population. clinicians treating older adults with mental disorders need better information on the risks and expected benefits of available therapies and on strategies for optimizing outcomes in this age group. more research is needed that evaluates the impact of aging and aging-related chronic illnesses on mental health care in middle-aged to older adults, that conjointly considers both the efficacy/effectiveness and the safety of therapies as equally important components of overall outcome. research is also needed that develops and advances interventions tailored to the specific needs of older adults with mental disorders in multiple intervention modalities (pharmacological, psychosocial, neurostimulationory device-based) and their combinations. as such, the nimh is encouraging the submission of such trials through these funding mechanisms, based on the stage of testing needed:examples of nimh studies that are encouraged through this notice include, but are not limited to those that:application and submission informationthis notice applies to due dates on or after june 5, 2020 and subsequent receipt dates through september 8, 2023.submit applications for this initiative using one of the following funding opportunity announcements (foas) or any reissues of these announcement through the expiration date of this notice.all instructions in the sf424 (r&r) application guide and the funding opportunity announcement used for submission must be followed, with the following additions:inquiriesscientific/research contact(s)jovier d. evans, phd.nimh/division of translational research telephone: {301-443-1369} email: jevans1@mail.nih.govpeer review contact(s)nicholas gaiano, ph.d. national institute of mental health (nimh) telephone: 301-827-3420 email: nick.gaiano@nih.govfinancial/grants management contact(s)rita sisconational institute of mental healthgrants management branchtelephone 301-443-2805email: siscor@mail.nih.govweekly toc for this announcement nih funding opportunities and noticesnote: for help accessing pdf, rtf, ms word, excel, powerpoint, audio or video files, see help downloading files.